Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2011-12-02Clinical Trial Update: Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines [Phase 1, Phase 2]
A Phase 1/2 trial evaluating hTERT mRNA-transfected dendritic cell vaccines for metastatic prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-03-18Clinical Trial Update: Open-Label, Randomised Parallel-Group Study [Phase 3]
A Phase 3 open-label randomized study for prostate cancer sponsored by Ferring Pharmaceuticals was withdrawn from the trial registry.
-
CLINICAL_TRIALS withdrawal · 2007-08-28Clinical Trial Update: CMAB vs IMAB in Metastatic Prostate Cancer [Phase 4]
A Phase 4 clinical trial comparing CMAB and IMAB in metastatic prostate cancer has been withdrawn.